JPWO2022154116A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022154116A5 JPWO2022154116A5 JP2022575662A JP2022575662A JPWO2022154116A5 JP WO2022154116 A5 JPWO2022154116 A5 JP WO2022154116A5 JP 2022575662 A JP2022575662 A JP 2022575662A JP 2022575662 A JP2022575662 A JP 2022575662A JP WO2022154116 A5 JPWO2022154116 A5 JP WO2022154116A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- affinity peptide
- amino acid
- linker
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025085873A JP2025124732A (ja) | 2021-01-18 | 2025-05-22 | 化合物またはその塩、およびそれらにより得られる抗体 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021005762 | 2021-01-18 | ||
| JP2021005762 | 2021-01-18 | ||
| PCT/JP2022/001358 WO2022154116A1 (ja) | 2021-01-18 | 2022-01-17 | 化合物またはその塩、およびそれらにより得られる抗体 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025085873A Division JP2025124732A (ja) | 2021-01-18 | 2025-05-22 | 化合物またはその塩、およびそれらにより得られる抗体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JPWO2022154116A1 JPWO2022154116A1 (https=) | 2022-07-21 |
| JPWO2022154116A5 true JPWO2022154116A5 (https=) | 2025-01-27 |
| JP7687350B2 JP7687350B2 (ja) | 2025-06-03 |
Family
ID=82448186
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022575662A Active JP7687350B2 (ja) | 2021-01-18 | 2022-01-17 | 化合物またはその塩、およびそれらにより得られる抗体 |
| JP2025085873A Pending JP2025124732A (ja) | 2021-01-18 | 2025-05-22 | 化合物またはその塩、およびそれらにより得られる抗体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025085873A Pending JP2025124732A (ja) | 2021-01-18 | 2025-05-22 | 化合物またはその塩、およびそれらにより得られる抗体 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20240000965A1 (https=) |
| EP (1) | EP4279500A4 (https=) |
| JP (2) | JP7687350B2 (https=) |
| KR (1) | KR20230133294A (https=) |
| CN (1) | CN116829573A (https=) |
| AU (1) | AU2022208654B2 (https=) |
| CA (1) | CA3208296A1 (https=) |
| WO (1) | WO2022154116A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPWO2020090979A1 (ja) * | 2018-10-31 | 2021-09-24 | 味の素株式会社 | 抗体に対する親和性物質、切断性部分および反応性基を有する化合物またはその塩 |
| WO2023234416A1 (ja) | 2022-06-02 | 2023-12-07 | 味の素株式会社 | 親和性物質、化合物、抗体およびそれらの塩 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL106992A (en) | 1988-02-11 | 1994-06-24 | Bristol Myers Squibb Co | Acylhydrazone derivatives of anthracycline and methods for their preparation |
| US5622929A (en) | 1992-01-23 | 1997-04-22 | Bristol-Myers Squibb Company | Thioether conjugates |
| US6214345B1 (en) | 1993-05-14 | 2001-04-10 | Bristol-Myers Squibb Co. | Lysosomal enzyme-cleavable antitumor drug conjugates |
| DK0871490T3 (da) | 1995-12-22 | 2003-07-07 | Bristol Myers Squibb Co | Forgrenede hydrazonlinkere |
| EP1243276A1 (en) | 2001-03-23 | 2002-09-25 | Franciscus Marinus Hendrikus De Groot | Elongated and multiple spacers containing activatible prodrugs |
| DK1545613T3 (da) | 2002-07-31 | 2011-11-14 | Seattle Genetics Inc | Auristatinkonjugater og deres anvendelse til behandling af cancer, en autoimmun sygdom eller en infektiøs sygdom |
| WO2004043493A1 (en) | 2002-11-14 | 2004-05-27 | Syntarga B.V. | Prodrugs built as multiple self-elimination-release spacers |
| EP2478912B1 (en) | 2003-11-06 | 2016-08-31 | Seattle Genetics, Inc. | Auristatin conjugates with anti-HER2 or anti-CD22 antibodies and their use in therapy |
| DE102004026304B3 (de) | 2004-05-28 | 2005-08-25 | Atlas Elektronik Gmbh | Prüfverfahren für ein Verfahren zur passiven Gewinnung von Zielparamentern |
| JP5827769B1 (ja) | 2015-03-27 | 2015-12-02 | 義徳 川窪 | 掃除装置 |
| ES3058443T3 (es) * | 2015-05-20 | 2026-03-10 | Univ Kagoshima | Modificación específica de anticuerpo con péptido de unión a IgG |
| AU2018259856B2 (en) * | 2017-04-28 | 2025-05-01 | Ajinomoto Co., Inc. | Compound having substance that has affinity for soluble protein, cleavable moiety, and reactive group, or salt thereof |
| JPWO2019240288A1 (ja) | 2018-06-14 | 2021-07-26 | 味の素株式会社 | 抗体に対する親和性物質、および生体直交性官能基を有する化合物またはその塩 |
| KR102921757B1 (ko) | 2018-06-14 | 2026-02-03 | 아지노모토 가부시키가이샤 | 항체에 대한 친화성 물질, 절단성 부분 및 반응성기를 갖는 화합물 또는 이의 염 |
| WO2020009165A1 (ja) | 2018-07-03 | 2020-01-09 | 味の素株式会社 | 修飾抗体およびその製造方法 |
| JP6581254B1 (ja) | 2018-07-09 | 2019-09-25 | セイコーソリューションズ株式会社 | クロック調整装置及びプログラム |
| JP6677281B2 (ja) | 2018-08-23 | 2020-04-08 | ブラザー工業株式会社 | インクジェット記録装置、及びプログラム |
| JPWO2020090979A1 (ja) | 2018-10-31 | 2021-09-24 | 味の素株式会社 | 抗体に対する親和性物質、切断性部分および反応性基を有する化合物またはその塩 |
| JP7110955B2 (ja) | 2018-12-04 | 2022-08-02 | トヨタ自動車株式会社 | インホイールモータ |
-
2022
- 2022-01-17 CA CA3208296A patent/CA3208296A1/en active Pending
- 2022-01-17 CN CN202280010420.0A patent/CN116829573A/zh active Pending
- 2022-01-17 WO PCT/JP2022/001358 patent/WO2022154116A1/ja not_active Ceased
- 2022-01-17 JP JP2022575662A patent/JP7687350B2/ja active Active
- 2022-01-17 AU AU2022208654A patent/AU2022208654B2/en active Active
- 2022-01-17 EP EP22739521.7A patent/EP4279500A4/en active Pending
- 2022-01-17 KR KR1020237024074A patent/KR20230133294A/ko active Pending
-
2023
- 2023-07-18 US US18/354,436 patent/US20240000965A1/en active Pending
-
2025
- 2025-05-22 JP JP2025085873A patent/JP2025124732A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPWO2022154116A5 (https=) | ||
| JP2020513019A5 (https=) | ||
| JP2020519643A5 (https=) | ||
| JP2023052910A5 (https=) | ||
| RU2010116152A (ru) | Антитело против рецептора il-6 | |
| JPWO2022191283A5 (https=) | ||
| RU2010136029A (ru) | Композиция, содержащая антитело, которое связывается с доменом ii her2, и его кислые варианты | |
| AR040046A1 (es) | Anticuerpo neutralizante humano anti-igfr | |
| Ishida et al. | Highly effective binding of phosphomonoester with neutral cyclic peptides which include a non-natural amino acid | |
| Kuby et al. | Studies on adenosine triphosphate transphosphorylases. Amino acid sequence of rabbit muscle ATP-AMP transphosphorylase | |
| RU2001119328A (ru) | Применение металлоорганического соединения для защиты и/или усиления кератиновых материалов и способ обработки | |
| JP2011505146A5 (https=) | ||
| JP2020506685A5 (https=) | ||
| JP2019512500A5 (https=) | ||
| JP2009529509A5 (https=) | ||
| JP2019506140A5 (https=) | ||
| JPWO2023234416A5 (https=) | ||
| CA2382035C (fr) | Composes synthetiques portant deux epitopes pour immunodosages | |
| Steiner et al. | Crystallizable human myeloma protein Dob has a hinge-region deletion | |
| JP2006503088A5 (https=) | ||
| Ottl et al. | A new strategy for regioselective interstrand disulfide bridging of multiple cysteine peptides | |
| JP2022514348A5 (https=) | ||
| Inman et al. | Synthesis of N. alpha.-(tert-butoxycarbonyl)-N. epsilon.-[N-(bromoacetyl)-. beta.-alanyl]-L-lysine: Its use in peptide synthesis for placing a bromoacetyl cross-linking function at any desired sequence position | |
| Wade et al. | Use of thiazolidine-mediated ligation for site specific biotinylation of mouse EGF for biosensor immobilisation | |
| JPWO2022154127A5 (https=) |